Standard BioTools Inc (NASDAQ: LAB) is -42.29% lower on its value in year-to-date trading and has touched a low of $1.00 and a high of $3.04 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LAB stock was last observed hovering at around $1.07 in the last trading session, with the day’s loss setting it -0.06%.
Currently trading at $1.01, the stock is -23.11% and -37.22% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.2 million and changing -5.16% at the moment leaves the stock -46.80% off its SMA200. LAB registered -57.38% loss for a year compared to 6-month loss of -51.44%.
The stock witnessed a -37.27% gain in the last 1 month and extending the period to 3 months gives it a -40.94%, and is -24.06% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.00% over the week and 8.48% over the month.
Standard BioTools Inc (LAB) has around 539 employees, a market worth around $375.99M and $174.43M in sales. Profit margin for the company is -106.00%. Distance from 52-week low is 1.00% and -66.78% from its 52-week high. The company has generated returns on investments over the last 12 months (-37.09%).
with sales reaching $40.1M over the same period.The EPS is expected to grow by 65.38% this year, but quarterly earnings will post -3.00% year-over-year. Quarterly sales are estimated to shrink -11.95% in year-over-year returns.
Standard BioTools Inc (LAB) Top Institutional Holders
The shares outstanding are 372.26M, and float is at 360.49M with Short Float at 3.74%.
The top institutional shareholder in the company is CASDIN CAPITAL, LLC with over 63.96 million shares valued at $113.21 million. The investor’s holdings represent 17.1782% of the LAB Shares outstanding. As of 2024-06-30, the second largest holder is VIKING GLOBAL INVESTORS LP with 58.65 million shares valued at $103.81 million to account for 15.7524 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 21.75 million shares representing 5.8424% and valued at over $38.5 million, while VANGUARD GROUP INC holds 4.2981 of the shares totaling 16.0 million with a market value of $28.33 million.
Standard BioTools Inc (LAB) Insider Activity
A total of 0 insider transactions have happened at Standard BioTools Inc (LAB) in the last six months, with sales accounting for 0 and purchases happening 0 times.
Still, SEC filings show that on Aug 27 ’24, Casdin Partners Master Fund, L (Director) acquired 250,000 shares at an average price of $2.19 for $0.55 million. The insider now directly holds 54,025,821 shares of Standard BioTools Inc (LAB).
Standard BioTools Inc (LAB): Who are the competitors?
The company’s main competitors (and peers) include Thermo Fisher Scientific Inc. (TMO) that is trading -9.97% down over the past 12 months. Pacific Biosciences of California Inc. (PACB) that is -73.05% lower over the same period.
